SAB Biotherapeutics, Inc.
NASDAQSABS short interest drops 18.7% in one day to 5.0% of float, down 20.9% over the past week.
Snapshot as of 23 Jun 2026
SAB Biotherapeutics heads into its May 12 Q1 print with options positioning making a dramatic U-turn — and a hantavirus catalyst generating fresh trader attention. The starkest move in the setup is in the options…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for SABS — free to start on ORTEX.
Sign up for free →Open SABS on ORTEXPulses are triggered by ORTEX's live data feeds. The full signal history, thresholds, and alerts are on ORTEX.
Live SABS data →